The future of healthcare is here, and it's in your pocket. Imagine a world where your smartphone becomes a powerful tool to detect hidden health risks, potentially saving lives and revolutionizing the way we approach medical care. This is the exciting prospect presented by a groundbreaking study from Karolinska Institutet and Danderyd Hospital, which has shown that smartphone-based heart rhythm monitoring can significantly reduce unnecessary healthcare visits and improve patient outcomes.
The study, published in JAMA Cardiology, focused on atrial fibrillation, a common cardiac arrhythmia that affects adults. Atrial fibrillation causes the heart to beat irregularly and often too fast, and when medication fails to control symptoms, electrical cardioversion is used to restore the heart's normal rhythm. However, this procedure requires skilled staff and careful patient preparation, and a practical challenge is that many patients spontaneously return to normal heart rhythm ahead of treatment, leading to last-minute cancellations and wasted resources.
The solution? A technology called CORAI, which uses photoplethysmography (PPG) to measure small changes in blood flow in the fingertip. Based on these pulse waves, heart rhythm can be assessed with high accuracy. Patients in the active monitoring group recorded their heart rhythm twice daily using a smartphone for one to two weeks ahead of their planned cardioversion. If the recordings showed that a patient had spontaneously returned to normal heart rhythm, the patient was contacted, the rhythm was confirmed with a standard ECG, and the cardioversion could be cancelled in advance.
The results were remarkable. In the monitored group, only 4.8% of cardioversions were cancelled on the same day, compared with 23.2% in the control group. When looking specifically at late cancellations caused by spontaneous return to normal heart rhythm, the difference was even greater: 1.0% in the intervention group compared with 18.2% in the control group, corresponding to a relative risk reduction of 94.7%.
What makes this particularly fascinating is the potential for early detection and the ability to provide healthcare providers with information that might otherwise be missed. In the control group, many patients had recordings showing normal heart rhythm before cardioversion, but only three contacted their healthcare provider to discuss cancelling their planned procedure. This shows that objective heart rhythm monitoring at home can provide healthcare providers with information that might otherwise be missed.
The study also highlights the potential for smartphone-based heart rhythm diagnostics to improve access to heart rhythm assessment more generally. Among the patients who participated in the study, 99% owned a smartphone even though the median age was 70 years. This means that smartphone-based heart rhythm diagnostics has the potential to improve access to heart rhythm assessment more generally.
The implications of this research are far-reaching. Untreated atrial fibrillation increases the risk of stroke and heart failure, so early detection is crucial. In upcoming research projects, the team will study how effective the method is at detecting previously unknown atrial fibrillation compared with current methods used in healthcare.
However, it's important to note that while the technology shows great promise, it's not a panacea. The study was funded by Vinnova and the Swedish Heart-Lung Foundation, and Jonatan Fernstad, the founder of Corai Medicinteknik AB, has received fees and grants from pharmaceutical/medtech companies. Full disclosure of all authors' interests is available in the scientific article.
In my opinion, this study represents a significant step forward in the use of technology to improve healthcare outcomes. It shows that smartphone-based heart rhythm monitoring can significantly reduce unnecessary healthcare visits and improve patient outcomes, and it opens up exciting possibilities for early detection and improved access to heart rhythm assessment. As we move forward, it will be fascinating to see how this technology develops and how it can be integrated into mainstream healthcare.
